Reliable access to human biospecimens is essential for biomedical research. Yet
successful biospecimen sourcing involves much more than collecting and shipping
samples. It requires strong relationships with clinical institutions, an
understanding of their capabilities, and a shared commitment to scientific
quality and responsible research practices.
At IBS Global, developing these relationships is the key part of how we build
and strengthen our international partner network.
Engaging Clinical Institutions in Biomedical Research
On October 22, IBS GL organized an educational webinar in Chile titled “Before
Clinical Trials: The Role of Human Biospecimens in Preclinical and Translational
Research.”
The session featured Dr. Elmira Safarova, IBS GL Country Representative in
Chile, and Dr. Alicia Colombo, Scientific Director of the Tissue and Fluid
Biobank at the University of Chile.
The webinar explored the role of human biospecimens in drug discovery and
translational research, the scientific value of clinical sample collections, and
the opportunities for hospitals, pathology laboratories, and biobanks to
contribute to international research.
Particular attention was given to the factors that determine whether
biospecimens are suitable for research, including sample quality, clinical
characterization, traceability, and ethical and regulatory requirements.
Why Partner Education Matters
Healthcare institutions generate and preserve biological materials as part of
routine clinical practice. However, participating in international research
requires additional knowledge, processes, and institutional coordination.
By engaging directly with potential partners, IBS GL aims to create a shared
understanding of research needs, technical requirements, and responsible
approaches to biospecimen use.
These conversations help institutions assess their potential contribution to
biomedical research while enabling IBS GL to better understand local
capabilities and operational considerations.
Building a Stronger Global Biospecimen Network
Our approach to partner development goes beyond individual sample requests.
We believe that sustainable biospecimen sourcing depends on long-term
relationships, transparent communication, and alignment between the needs of
researchers and the capabilities of clinical institutions.
Educational initiatives such as the Chile webinar are one way IBS GL supports
this approach.
As we continue developing our international network, we remain focused on
connecting biomedical research organizations with institutions capable of
contributing high-quality, well-characterized human biospecimens through
appropriate ethical and regulatory processes.
Interested in collaborating with IBS GL?
Whether you represent a hospital, pathology laboratory, biobank, pharmaceutical
company, biotechnology company, or CRO, we welcome conversations about potential
research partnerships and biospecimen sourcing opportunities.
Contact us or write to info@ibsgl.com.
